BTIG Research Lowers Atlassian (NASDAQ:TEAM) Price Target to $140.00

Atlassian (NASDAQ:TEAM) had its price objective lowered by BTIG Research from $220.00 to $140.00 in a research note issued on Friday, MarketBeat reports. The brokerage currently has a “buy” rating on the technology company’s stock. BTIG Research’s price target would indicate a potential upside of 47.80% from the company’s current price.

A number of other research analysts also recently weighed in on TEAM. Truist Financial set a $210.00 price objective on Atlassian in a research note on Friday, October 31st. Piper Sandler reissued an “overweight” rating on shares of Atlassian in a research report on Tuesday, January 13th. Sanford C. Bernstein boosted their price objective on shares of Atlassian from $290.00 to $304.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 18th. Cantor Fitzgerald lowered their target price on shares of Atlassian from $240.00 to $146.00 and set an “overweight” rating on the stock in a research note on Wednesday. Finally, Macquarie Infrastructure cut their target price on shares of Atlassian from $250.00 to $240.00 and set an “outperform” rating for the company in a research report on Monday, November 3rd. Twenty equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Atlassian has an average rating of “Moderate Buy” and a consensus price target of $191.32.

Atlassian Stock Performance

Shares of TEAM opened at $94.72 on Friday. The firm has a market cap of $24.92 billion, a price-to-earnings ratio of -131.55, a price-to-earnings-growth ratio of 14.67 and a beta of 0.88. The company’s fifty day moving average is $144.50 and its 200-day moving average is $158.18. The company has a quick ratio of 1.26, a current ratio of 1.26 and a debt-to-equity ratio of 0.72. Atlassian has a 12 month low of $92.32 and a 12 month high of $326.00.

Atlassian (NASDAQ:TEAM) last issued its quarterly earnings data on Thursday, February 5th. The technology company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.12 by $0.10. Atlassian had a negative net margin of 3.29% and a negative return on equity of 6.60%. The firm had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.54 billion. During the same period in the prior year, the company posted $0.96 earnings per share. Atlassian’s revenue for the quarter was up 23.3% on a year-over-year basis. Equities analysts expect that Atlassian will post -0.34 EPS for the current fiscal year.

Insider Activity

In related news, CEO Michael Cannon-Brookes sold 7,665 shares of Atlassian stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $94.81, for a total transaction of $726,718.65. Following the sale, the chief executive officer directly owned 275,940 shares of the company’s stock, valued at $26,161,871.40. This trade represents a 2.70% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Scott Farquhar sold 7,665 shares of the company’s stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $94.81, for a total value of $726,718.65. Following the completion of the transaction, the director directly owned 275,940 shares of the company’s stock, valued at approximately $26,161,871.40. This trade represents a 2.70% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 566,379 shares of company stock valued at $82,730,694. 36.66% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Atlassian

A number of institutional investors have recently bought and sold shares of the business. Physician Wealth Advisors Inc. raised its stake in shares of Atlassian by 60.4% in the 3rd quarter. Physician Wealth Advisors Inc. now owns 162 shares of the technology company’s stock valued at $26,000 after buying an additional 61 shares in the last quarter. GAMMA Investing LLC increased its stake in Atlassian by 12.0% in the fourth quarter. GAMMA Investing LLC now owns 615 shares of the technology company’s stock valued at $100,000 after acquiring an additional 66 shares during the period. Snowden Capital Advisors LLC increased its stake in Atlassian by 1.6% in the second quarter. Snowden Capital Advisors LLC now owns 4,464 shares of the technology company’s stock valued at $907,000 after acquiring an additional 71 shares during the period. Financial Perspectives Inc raised its position in Atlassian by 11.7% in the fourth quarter. Financial Perspectives Inc now owns 718 shares of the technology company’s stock worth $116,000 after purchasing an additional 75 shares in the last quarter. Finally, Cetera Investment Advisers lifted its stake in Atlassian by 0.3% during the second quarter. Cetera Investment Advisers now owns 24,808 shares of the technology company’s stock worth $5,038,000 after purchasing an additional 79 shares during the period. Institutional investors and hedge funds own 94.45% of the company’s stock.

Atlassian News Roundup

Here are the key news stories impacting Atlassian this week:

• Positive Sentiment: Q2 beat — Atlassian reported $1.22 EPS vs. $1.12 expected and revenue of $1.59B (vs. $1.54B est.), with revenue up ~23% y/y, a near-term fundamental positive for growth momentum. Atlassian Q2 Earnings Surpass Expectations
• Positive Sentiment: Management raised its fiscal 2026 revenue forecast, citing resilient enterprise spending and accelerating AI adoption — supports the company’s multi-quarter revenue outlook. Atlassian Raises Annual Revenue Forecast (Reuters)
• Positive Sentiment: Company targets 20%+ annual revenue growth through FY27 and cites record cloud revenue and AI integrations — a constructive strategic signal if execution continues. Seeking Alpha: Growth Target
• Positive Sentiment: Unusual options activity — a spike to ~14,021 calls purchased (≈51% above normal), which can indicate tactical bullish positioning by traders.
• Neutral Sentiment: Analysts trimmed price targets but kept favorable ratings (Morgan Stanley, Mizuho, BTIG among others) — reduces near-term implied upside but preserves buy/overweight bias. Benzinga: Analyst Target Changes
• Negative Sentiment: Insider selling — directors/co‑founders disclosed multiple recent sales (7,665 shares each), a visible negative for investor sentiment and a factor pressuring the stock. SEC Filing: Insider Sales
• Negative Sentiment: Cantor Fitzgerald and some other brokers cut price targets sharply (e.g., Cantor to $146), and sector-wide AI fears are amplifying downside pressure. Cantor Fitzgerald Target Cut
• Negative Sentiment: Market reaction: coverage notes shares dipped despite the beat as investors worry cloud growth may slow and AI competition/feature rollouts elsewhere increase volatility. Investing.com: Shares Dip

Atlassian Company Profile

Atlassian Corporation Plc is a software company headquartered in Sydney, Australia, best known for developing collaboration, project management and software development tools. Founded in 2002 by Mike Cannon-Brookes and Scott Farquhar, Atlassian grew from a small engineering-focused team into a publicly traded company after its initial public offering in 2015. The company serves a global customer base that spans small teams to large enterprises across technology, financial services, government and other sectors.

Atlassian’s product portfolio centers on tools designed to help teams plan, build and support software and business processes.